Enterome’s OncoMimic technology allows the overcoming of immune tolerance against cancer cells, with broad applicability against solid tumor via an off-the-shelf, easy to manufacture technology. Enterome’s potentially first-in-class small protein and peptide drug candidates modulate the immune system by closely mimicking the structure, effect oractions of Tumor Associated Antigens to induce a potent, endogenous CD8 T cell response. The company’s most advanced programs are in Phase 2 clinical trials in hard-to-treat tumors such as glioblastoma, adrenal malignancies and colorectal cancer.

Biotechnology

Health Care

Life Sciences

Therapeutics

Enterome

Belichard Pierre

Marie-Laure Bouttier

Jan Fagerberg

Pierre Sahakian

Jean-Michel Paillarse

Christelle Dumoussaud

The Research and Development team at Enterome focuses on the discovery, design, and advancement of small protein and peptide drug candidates that modulate the immune system to fight cancer. This team conducts preclinical and clinical studies, analyzes data to optimize therapeutic efficacy, identifies biomarkers, and collaborates across disciplines to translate innovative research into viable treatments, currently targeting hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.

Research and Development

The Leadership Team at Enterome is responsible for steering the company's strategic direction, managing its operations, and overseeing the development and clinical progress of its innovative OncoMimic technology. This team comprises key executives who ensure the alignment of Enterome's business objectives with its mission to advance breakthrough cancer immunotherapies. They handle critical decision-making processes, financial oversight, clinical trial management, and corporate governance to achieve regulatory approval and commercial success for the company's drug candidates.

Leadership Team

The Clinical Development team at Enterome is responsible for overseeing and managing the progression of Enterome’s innovative drug candidates through the clinical trial phases. This includes coordinating clinical trial operations, developing project timelines, managing resources, and ensuring compliance with regulatory standards to advance the OncoMimic technology from Phase 2 trials through to potential market approval.

Enterome

Org chart

Teams

Research and Development

Leadership Team

Clinical Development

Offices

Enterome

Org chart

Teams

Research and Development

Leadership Team

Clinical Development

Offices

Related companies